Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000629

Drug Information
NameRomiplostim
CompanyAmgen
IndicationChemotherapy-induced thrombocytopenia and Myelodysplastic syndromes
[ICD9: 238.7, 287.3, 287.4, 287.5   ICD10: D46, D69.6, P61.0]
Phase II    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C15H14N2O/c1-9-7-10(2)16-14(9)8-12-11-5-3-4-6-13(11)17-15(12)1
8/h3-8,16H,1-2H3,(H,17,18)/b12-8-
InChIKeyWUWDLXZGHZSWQZ-WQLSENKSSA-N
Canonical SMILESCC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C    
Isomeric SMILESCC1=CC(=C(N1)/C=C\2/C3=CC=CC=C3NC2=O)C
CAS NumberCAS 267639-76-9
PubChem Compound IDCID 5329098.
SuperDrug ATC IDB02BX04
B02BX04
ClinicalTrials.govNCT00303472;
TargetC1 esteraseInhibitor[2][3]
Ref 1Emerging drugs for idiopathic thrombocytopenic purpura in adults. Expert Opin Emerg Drugs. 2008 Jun;13(2):237-54. To Reference
Ref 2Amgen. Product Development Pipeline. February 6 2009. To Reference
Ref 3Amgen. Report of Amgen. January 2009. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543